The advertisement promotes Kyprolis (carfilzomib) as a treatment for relapsed refractory multiple myeloma (RRMM), highlighting its efficacy and safety information.
Creative Information
| CID: | f453f48e-ec2a-4f26-b2d6-739385671342 |
| CRID: | 89_209824 |
| Domain: | kyprolis.com |
| Seat: | DInt |
| Size: | 300x250 |
| Bid: | $3.59 |
| Timestamp: | 11/20/2025, 4:39:37 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/20/2025, 5:40:17 PM | 6.94s | |
| adomain_analysis | success | 11/20/2025, 6:33:06 PM | 4.57s | |
| adomain_capture | success | 11/20/2025, 6:33:01 PM | 0.17s | |
| ad_render | success | 11/20/2025, 5:40:10 PM | 34.76s | |
| brand_mapping | success | 11/20/2025, 4:39:38 PM | 0.12s | |
Analysis Results
Ad Format: banner
Brands: Kyprolis
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1373.79 KB | ||||||||||||||||||||||
| Render Time: | 10.12 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1373.88 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


